Lucira Covid-19 test is first to get FDA nod for home use
The authorization comes as Covid-19 testing demand threatens to swamp U.S. labs. However, it will take time for the Lucira test to become available nationwide.
Startups pause at-home tests after new FDA guidance
Everlywell, Nurx, and a bevy of other companies had begun marketing at-home tests as the U.S. still faces a shortage. But they had to stop after the Food and Drug Administration clarified that it had not approved at-home testing.
The Power of One: Redefining Healthcare with an AI-Driven Unified Platform
In a landscape where complexity has long been the norm, the power of one lies not just in unification, but in intelligence and automation.